Teva Aims To Be Japan’s Top Generic Maker By 2018
This article was originally published in PharmAsia News
Executive Summary
Teva aims to be the top generic pharmaceutical company in Japan by 2018, according to an announcement in Tokyo by CEO Ichiro Kikushige on Sept. 3.